logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Journal of Thoracic Oncology cover

Journal of Thoracic Oncology

IF20.8
Papers784
Citations27302
Journal Papers 736
Publication Date
delete
A Response to the Letter to the Editor: “Percent Thymic Tissue and Pneumonitis Risk in Locally Advanced NSCLC: From Predictive Signal to Clinical Actionability”
deleteJournal of Thoracic Oncology
IF20.8
delete2026-10-02
delete0
PREAI
deleteTafadzwa L. Chaunzwa
deleteShare
deleteSave
Large Cell Neuroendocrine Carcinoma: Rethinking the Path to Better Therapies
deleteJournal of Thoracic Oncology
IF20.8
delete2026-10-02
delete0
PREAI
deleteKelsie L. Thu; Ming-Sound Tsao
deleteShare
deleteSave
Can Postoperative Pathology Guide Preoperative Segmentectomy Decisions?
deleteJournal of Thoracic Oncology
IF20.8
delete2026-10-02
delete0
PREAI
deleteXichen Fan; Zhengyan Yang; Huiru Li; Gong Zhang
deleteShare
deleteSave
Significant by Chance: Revisiting the Evidence for Segmentectomy
deleteJournal of Thoracic Oncology
IF20.8
delete2026-10-02
delete0
PREAI
deleteEric Lim
deleteShare
deleteSave
Percent Thymic Tissue and Pneumonitis Risk in Locally Advanced NSCLC: From Predictive Signal to Clinical Actionability
deleteJournal of Thoracic Oncology
IF20.8
delete2026-10-02
delete0
PREAI
deleteGong Zhang; Zhe Zhao; Yibing Liu
deleteShare
deleteSave
A Response to the Letter to the Editor: “Can postoperative pathology guide preoperative segmentectomy decisions?”
deleteJournal of Thoracic Oncology
IF20.8
delete2026-10-02
delete0
PREAI
deleteShinya Katsumata; Mitsuhiro Isaka; Masaya Yotsukura; Keiju Aokage
deleteShare
deleteSave
Beyond BMI: Is Visceral Adiposity Reframing the Obesity Paradox in Lung Cancer?
deleteJournal of Thoracic Oncology
IF20.8
delete2026-10-02
delete0
PREAI
deleteDaniel Ajona; Javier Gómez-Ambrosi
deleteShare
deleteSave
No Longer a Luxury? MRD Dynamics as the Final Arbitrator for Cure in Locally Advanced NSCLC
deleteJournal of Thoracic Oncology
IF20.8
delete2026-10-02
delete0
PREAI
deleteNicolas Girard
deleteShare
deleteSave
Gene-Specific Analysis of Clonal Hematopoiesis Identifies the Association between ASXL1 and Lung Cancer Risk
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-28
delete0
PREAI
deleteZijian Zhang; Jing Dong; Yun Huang; Yanhong Liu; Christopher I. Amos; Chao Cheng
deleteShare
deleteSave
Efficacy and safety of HER2 directed therapies for advanced HER2-mutant non-small-cell lung cancer – a systematic review and meta-analysis
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-28
delete0
PREAI
deleteMolly S.C. Li; Yu Yang Soon; Pui Yin Au-Yeung; Andrew L.S. Chan; Jii-Bum Lee; Jorn Nutzinger; Akiko Tateishi; Ross Soo
deleteShare
deleteSave
A Response to the Letter to the Editor: “Central Adiposity, Confounding Medications, and the Reinterpretation of the “Obesity Paradox” in Lung Cancer Risk”
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-25
delete0
PREAI
deleteJoseph Barbi; Santosh K. Patnaik; Sai Yendamuri
deleteShare
deleteSave
Genomic and transcriptomic features of relapsed small cell lung cancer
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-17
delete0
PREAI
deleteSiddhartha Devarakonda; My Hoang; Sumithra Sankararaman; Zach L. Skidmore; Brett H. Herzog; Kymberlie Pepin; Joshua McMichael; Jeffrey P. Ward; Daniel Morgensztern; Saiama Naheed Waqar; Angela Brinker; Trudy G. Oliver; Malachi Griffith; Obi L. Griffith; Ramaswamy Govindan
deleteShare
deleteSave
Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer in a Phase 2 Study
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-17
delete0
PREAI
deleteTodd M. Bauer; Jean-François Martini; Benjamin Besse; Chia-Chi Lin; Ross A. Soo; Gregory J. Riely; I-Ming Wang; Francesca Toffalorio; Deborah A. Shepard; Tiziana Usari (; Phineas Hamilton (; D. Ross Camidge; Steven Kao; Rita Chiari; Shirish Gadgeel; Enriqueta Felip; Alice T. Shaw; Benjamin J. Solomon
deleteShare
deleteSave
In the Era of Neoadjuvant Chemo-Immunotherapy for Resectable Locally Advanced Stage III NSCLC, Neoadjuvant Chemoradiotherapy Is No Longer a Standard of Care
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-04
delete0
PREAI
deleteBianca Battilana; Matthias Guckenberger; Andreas Wicki; Isabelle Opitz
deleteShare
deleteSave
Incorporation of Nonanatomic Histologic Factors Into a Staging System for Lung Cancer: Now Is the Time?
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-04
delete0
PREAI
deleteYu Zhi Zhang; Andrew G. Nicholson
deleteShare
deleteSave
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-04
delete0
PREAI
deleteSheng Yu; Xiushen Wang; Hong Ge
deleteShare
deleteSave
Will the Pauper (Deulorlatinib/TGRX-326) Take the CROWN From the Prince (Lorlatinib) in an Alternate Ending? Deuteration Is Here to Stay in Oncology
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-04
delete0
PREAI
deleteVivian Thuy Tieu; Emily Chou; Misako Nagasaka; Sai-Hong Ignatius Ou
deleteShare
deleteSave
In the Chemoimmunotherapy Era, There Is Still a Role for Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced NSCLC
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-04
delete0
PREAI
deleteSemih Ünal; Max Dahele; Ilias Houda; Suresh Senan; Idris Bahce; Chris Dickhoff
deleteShare
deleteSave
Author Reply: Re-Evaluating the Impact of KRAS Mutations in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-04
delete0
PREAI
deleteNikhil P. Mankuzhy; Valentina Santo; Biagio Ricciuti; Narek Shaverdian
deleteShare
deleteSave
Implications of Clinical and Genetic Management of Subjects With BAP1 Germline Variants
deleteJournal of Thoracic Oncology
IF20.8
delete2026-09-04
delete0
PREAI
deleteElizabeth Casey West; Filippo Lococo; Luigi Boccuto
deleteShare
deleteSave